Four Questions with Humayun "Hank" Chaudhry
Humayun “Hank” Chaudhry, DO, MACP is president and CEO of the Federation of State Medical Boards, the national non-profit representing the state medical and osteopathic boards that license and discipline physicians. He spoke with Ruth Reader at a Jefferson AI symposium about the draft guidance FSMB expects to issue before the end of December, what the right word even is for approving an AI, and where liability lands when something goes wrong.
This conversation has been edited for length and clarity.
Ruth Reader: As AI starts practicing aspects of medical treatment, how is the Federation of State Medical Boards thinking about its role in ensuring AI is up to the task?
Hank Chaudhry: Right now we're in the process of having lots of conversations to see what we can do. As you may know, we have a working group that has had some good conversations. We're probably weeks away from issuing a draft guidance, probably before the end of December, and we'll send that out broadly to stakeholders to get their feedback and input. We'd like to put something together for the state boards by April. That's our annual meeting.
`Upcoming Sessions
Live conversations with the people shaping healthcare.
AMA with Doximity CEO Jeff Tangney
Join Doximity CEO Jeff Tangney for a live Q&A on where clinicians are finding value with AI, how Doximity has evolved, and building a company from zero to IPO.
Office Hours
A live Q&A with Christina Farr and Ruth Reader, exclusively for Second Opinion Premium members. Thursday, November 19, 1:30–2:30 p.m. ET / 10:30–11:30 a.m. PT.
The Shift Left & the Impact of the Midterms on Healthcare
Democrats just took both chambers. Aneesh Chopra, Christopher Kerns and Mike Desjadon join Ruth Reader and Christina Farr live to talk through what they'll try to do on healthcare — and what's actually achievable under a Republican White House.
Is It Finally the Moment for Alternative Health Plans?
Register Here Employers are under growing pressure to control healthcare costs while improving access, outcomes, and the member experience. That has renewed
Type 2 Diabetes & Cardiometabolic Care: Wearables, AI & GLP-1s
Register Here The rise of wearables, GLP-1s, and AI is reshaping treatment for Type 2 diabetes, weight loss, and metabolic disease.
Verifying AI in Medicine: Is Healthcare AI Actually Ready for Deployment?
Is AI ready for real-world clinical care? Dr. Zak Kohane and Protege’s Engy Ziedan debate what it takes to safely trust AI in diagnosis and treatment, from benchmark performance and clinical evidence to whether we’re holding AI to a higher standard than humans.
Why Are Hospitals Hiring Chief AI Officers?
As AI moves from pilots into day-to-day healthcare operations, health systems are having to decide who should actually own the
Where are AI Agents Actually Working in Healthcare, and Why?
While the healthcare industry remains locked in a high-level debate over the theoretical potential of artificial intelligence, a select group of
Top Employers Share What Healthcare Startups Need to Know in 2026
As enterprise health purchasers face volatile medical cost trends and tightening operational margins, the standard vendor pitch of "improved clinical efficiency&